Volta Finance Ltd (LON:VTA) is the topic of conversation when Hardman & Co Analyst Mark Thomas joins DirectorsTalk Interviews. Mark talks us through his recent report entitled ‘What Volta brings..
In the week that sanctions imposed on Russia began to take a knock on effect on markets around the world. Poolbeg Pharma plc (LON:POLB) announced its audited results for the..
Goodbody Health Inc (AQSE:GDBY) Scientific Advisory Committee Chair Professor Clive Page caught up with DirectorsTalk for an exclusive interview to discuss how the pandemic altered people’s perception of their health,..
Oakley Capital Investments Limited (LON:OCI) is the topic of conversation when Hardman and Co’s Analyst Mark Thomas caught up with DirectorsTalk for an exclusive interview. Q1: Your recent report on..
Shield Therapeutics plc (LON:STX) is a commercial-stage pharma company delivering specialty products that address patients’ unmet medical needs, with an initial focus on iron deficiency (ID). Following the US launch..
Hammerson plc (LON:HMSO) has proposed a final dividend of 0.2 pence per ordinary share for the period ended 31 December 2021. The Board also intends to offer Shareholders an Enhanced..
Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has today announced the signing of a commercial contract with a new top 10 global pharmaceutical company by revenue, initially focusing..
Accrol Group Holdings plc (LON:ACRL), the UK’s leading independent tissue convertor, has announced that Dan Wright, Executive Chairman of Accrol, has purchased 1,000,000 ordinary shares of £0.001 each at an..
Goodbody Health Inc (AQSE: GDBY) has today announced (i) its intention to initiate a normal course issuer bid (“NCIB“) through the facilities of the Canadian Securities Exchange; and (ii) the..
